Ledger.Open graph →
SEC Form D · filed January 7, 2026

Dermata Therapeutics, Inc

Offering
$4.1M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Christopher Heymann · George Town, Cayman IslandsExecPankauz Shrestha · NEW YORK, NYDirectorChristopher Sacca · Jackson, WYDirectorClay Dumas · Jackson, WYDirectorWalter Arnold · SARASOTA, FLExecJoe M. Cope · Arlington, VADirectorLowercarbon Q>10 GP, LLC · Jackson, WYExecThomas W. Groves · New York, NYDirectorRyan O. Egeland · Maple Grove, MNDirectorJared Hutar · Maple Grove, MNDirectorKeith Kallmes · Maple Grove, MNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗